These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 17653496

  • 21. Long-term rivastigmine treatment in a routine clinical setting.
    Minthon L, Wallin AK, Eriksson S, Wattmo C, Andreasen N.
    Acta Neurol Scand; 2009 Mar; 119(3):180-5. PubMed ID: 18759798
    [Abstract] [Full Text] [Related]

  • 22. Alzheimer's disease: issues and challenges in primary care.
    Cotter VT.
    Nurs Clin North Am; 2006 Mar; 41(1):83-93, vi. PubMed ID: 16492455
    [Abstract] [Full Text] [Related]

  • 23. [Use of neuropsychological tests in the Cronos Project].
    Bianchi G, Gasparini M, Caffari B, Sorrentino GC, Bianchi C, Bruno G, Maggini M, Raschetti R, Vanacore N.
    Ann Ist Super Sanita; 2005 Mar; 41(1):69-74. PubMed ID: 16037653
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Tense prescriptions? Alzheimer medications and the anthropology of uncertainty.
    Leibing A.
    Transcult Psychiatry; 2009 Mar; 46(1):180-206. PubMed ID: 19293285
    [Abstract] [Full Text] [Related]

  • 26. [Dementia].
    Sjöbeck M, Nilsson C.
    Lakartidningen; 2009 Mar; 106(20):1369-73. PubMed ID: 19585832
    [No Abstract] [Full Text] [Related]

  • 27. Dementia with parkinsonism: what is the diagnosis?
    Chong MS, Vinters HV, Gustavson AR, Cummings JL.
    Rev Neurol Dis; 2004 Mar; 1(1):41-4. PubMed ID: 16397452
    [Abstract] [Full Text] [Related]

  • 28. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Feldman H, Anand R, Blesa R, Dubois B, Gray J, Homma A, Mohr E, Morris JC, Parys W, Raschig A, Robillard A.
    Alzheimer Dis Assoc Disord; 1997 Mar; 11 Suppl 3():61-4. PubMed ID: 9305520
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dementia.
    Warner J, Butler R.
    Clin Evid; 2002 Jun; (7):846-66. PubMed ID: 12230710
    [No Abstract] [Full Text] [Related]

  • 31. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Amaducci L, Baldereschi M, Doody R, Chandra V, Gaines AD.
    Alzheimer Dis Assoc Disord; 1997 Jun; 11 Suppl 3():19-21. PubMed ID: 9305509
    [No Abstract] [Full Text] [Related]

  • 32. [Nootropic drugs: definition, classification, mechanism of action, clinical effectiveness, substances].
    Kuhlmey J.
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):697-701. PubMed ID: 7975756
    [No Abstract] [Full Text] [Related]

  • 33. Medication for dementia.
    Matzo M, Hill JA.
    Am J Nurs; 2009 Sep; 109(9):73-4. PubMed ID: 19704241
    [No Abstract] [Full Text] [Related]

  • 34. [Challenging pharmacotherapy in dementia].
    Ihl R.
    MMW Fortschr Med; 2009 Mar 26; 151(13):46-8. PubMed ID: 19504818
    [No Abstract] [Full Text] [Related]

  • 35. [Therapy of Alzheimer disease].
    Kovács T.
    Neuropsychopharmacol Hung; 2009 Mar 26; 11(1):27-33. PubMed ID: 19731816
    [Abstract] [Full Text] [Related]

  • 36. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O.
    J Am Geriatr Soc; 2008 May 26; 56(5):946-7. PubMed ID: 18454755
    [No Abstract] [Full Text] [Related]

  • 37. [Living with lost individuality. Special concerns in medical care of severely demented Alzheimer patients].
    Rajna P.
    Ideggyogy Sz; 2010 Nov 30; 63(11-12):364-76. PubMed ID: 21413439
    [Abstract] [Full Text] [Related]

  • 38. Neuropsychiatric assessment of Alzheimer's disease and related dementias.
    Cummings JL, McPherson S.
    Aging (Milano); 2001 Jun 30; 13(3):240-6. PubMed ID: 11444257
    [Abstract] [Full Text] [Related]

  • 39. Verbal repetition in people with mild-to-moderate Alzheimer Disease: a descriptive analysis from the VISTA clinical trial.
    Cook C, Fay S, Rockwood K.
    Alzheimer Dis Assoc Disord; 2009 Jun 30; 23(2):146-51. PubMed ID: 19474572
    [Abstract] [Full Text] [Related]

  • 40. [Patient-relevant end points in Alzheimer's disease].
    Frölich L.
    Dtsch Med Wochenschr; 2006 May 12; 131(19 Suppl 1):S31-4. PubMed ID: 16688663
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.